A 75-year-old man with history of atrial fibrillation, ischaemic cardiomyopathy, and biventricular pacemaker implantable cardioverter-defibrillator presented with automated implantable cardioverter-defibrillator (AICD) discharge and worsened exertional dyspnoea and lower extremity oedema. Six months previously, he received a left ventricular assist device (LVAD) (HeartWare International Inc., Framingham, MA, USA), a thirdgeneration, continuous flow centrifugal pump, for destination therapy. AICD interrogation revealed development of atrial flutter coincident with worsening heart failure symptoms. Power consumption and pump diagnostics showed no LVAD malfunction. Cardioversion of atrial flutter followed transoesophageal echocardiography ( 
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